Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -2.7x - -3.0x | -2.9x |
| Selected Fwd P/E Multiple | -3.5x - -3.8x | -3.7x |
| Fair Value | ₩1,041 - ₩1,151 | ₩1,096 |
| Upside | 11.2% - 23.0% | 17.1% |
| Benchmarks | - | Full Ticker |
| HLscience Co., Ltd. | - | KOSDAQ:A239610 |
| HuM&C Co., Ltd. | - | KOSDAQ:A263920 |
| Coreana Cosmetics Co.,Ltd. | - | KOSDAQ:A027050 |
| Hyundai Bioscience Co., Ltd. | - | KOSDAQ:A048410 |
| KODI CO., LTD | - | KOSDAQ:A080530 |
| Bonne Co., Ltd. | - | KOSDAQ:A226340 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| A239610 | A263920 | A027050 | A048410 | A080530 | A226340 | |||
| KOSDAQ:A239610 | KOSDAQ:A263920 | KOSDAQ:A027050 | KOSDAQ:A048410 | KOSDAQ:A080530 | KOSDAQ:A226340 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 6.8% | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | -37.2% | NM- | NM- | NM- | ||
| Latest Twelve Months | -289.4% | -72.8% | -63.3% | -27.1% | 143.5% | -633.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -5.3% | -32.0% | 1.5% | -128.3% | -10.5% | -4.3% | ||
| Prior Fiscal Year | -5.4% | 21.3% | 2.1% | -152.9% | -7.8% | 0.2% | ||
| Latest Fiscal Year | -44.6% | 7.2% | 1.0% | -46.0% | 0.8% | -12.8% | ||
| Latest Twelve Months | -49.5% | 5.1% | 0.7% | -133.1% | 3.0% | -21.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -3.3x | 7.4x | 23.1x | -115.2x | 9.0x | -30.1x | ||
| Price / LTM Sales | 3.5x | 0.9x | 0.9x | 49.6x | 0.8x | 0.6x | ||
| LTM P/E Ratio | -7.0x | 18.5x | 133.6x | -37.3x | 28.4x | -3.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -37.3x | 18.5x | 133.6x | |||||
| Historical LTM P/E Ratio | -122.2x | -9.2x | 24.8x | |||||
| Selected P/E Multiple | -2.7x | -2.9x | -3.0x | |||||
| (x) LTM Net Income | (13,005) | (13,005) | (13,005) | |||||
| (=) Equity Value | 35,530 | 37,400 | 39,270 | |||||
| (/) Shares Outstanding | 42.0 | 42.0 | 42.0 | |||||
| Implied Value Range | 846.92 | 891.49 | 936.06 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 846.92 | 891.49 | 936.06 | 936.00 | ||||
| Upside / (Downside) | -9.5% | -4.8% | 0.0% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A239610 | A263920 | A027050 | A048410 | A080530 | A226340 | |
| Value of Common Equity | 61,115 | 44,925 | 71,725 | 531,094 | 70,417 | 39,267 | |
| (/) Shares Outstanding | 5.1 | 49.0 | 30.2 | 48.0 | 45.8 | 42.0 | |
| Implied Stock Price | 12,000.00 | 916.00 | 2,375.00 | 11,060.00 | 1,538.00 | 936.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 12,000.00 | 916.00 | 2,375.00 | 11,060.00 | 1,538.00 | 936.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |